Bio-Matrix Scientific Group, Inc. BMSN
Our next key level of resistance is going to be at .0024. If it can get past that, the next level is .003, and .004 (200DMA).
Amarantus Bioscience, Inc. AMBS
We first began talking about AMBS on November 6th. Another one on a serious uptrend; in the past 14 days of trading, the stock has seen just two days of closing in the red.
AMBS will be co-hosting an international symposium , the #C4CT Concussion Awareness Conference, “with the purpose of bringing thought leaders in the field of Traumatic Brain Injury (“TBI”) drug and diagnostic research & development, professional athletes, former professional athletes and celebrity sports figureheads that share the Company’s, TCMG’s and Brewer’s desire to support research into new TBI treatments, sports leagues who have social and fiduciary responsibilities to improve player safety and caring for former players previously affected by TBI and cognitive disorders, as well as other key stakeholders in the ongoing social discussion regarding head injuries and their side effects.”
We had stated before that we were looking for a break past .13, and that it would bring us into bluesky breakout mode, and now that it has done so, we’re going to hold onto our hats, because there’s no telling where it could stop. We’d like to see .13 hold as the new base level of support.
Apple, Inc. AAPL
AAPL was as low as 510.24 on Dec. 21st, and dipping as low as 504.66 on December 27th. With all of the hype coming from “fiscal cliff” negotiations, Monday’s big rally (closed at 532.1729) has the stock trading close to 550.00 premarket today.
MSSD, BTHR, FORC, PPHM, MDIN, CTIX, SNTL, DNYS, KWK, NOK